UNITEDHEALTH GROUP INC
UNHAPI behind this page
UNH Q3 2025 request
Playground key active
/api/financials?ticker=UNH&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Premiums Earned Net | 88,979 | 77,442 | +14.9% |
Show Business Segments breakouts |
|||
| Optum Health · Operating Segments | 5,055 | 5,818 | -13.1% |
| Optum · Unaffiliated Customers | 5,055 | 5,818 | -13.1% |
| UnitedHealthcare · Operating Segments | 83,924 | 71,624 | +17.2% |
Show Major Customers breakouts |
|||
| Unaffiliated Customers | 88,979 | 77,442 | +14.9% |
| Investment Income Interest And Dividend | 1,132 | 1,643 | -31.1% |
Show Business Segments breakouts |
|||
| Optum | 564 | 836 | -32.5% |
| Optum Health · Operating Segments | 472 | 614 | -23.1% |
| Optum Insight · Operating Segments | 41 | 104 | -60.6% |
| Optum Rx · Operating Segments | 51 | 118 | -56.8% |
| UnitedHealthcare · Operating Segments | 568 | 807 | -29.6% |
| Revenue | 113,161 | 100,820 | +12.2% |
Show Business Segments breakouts |
|||
| Optum | 69,177 | 63,925 | +8.2% |
| Optum Health · Operating Segments | 9,510 | 9,855 | -3.5% |
| Optum Health · Operating Segments | 15,918 | 15,448 | +3.0% |
| Optum Health · Operating Segments | 25,900 | 25,917 | -0.1% |
| Optum Insight · Operating Segments | 1,584 | 1,741 | -9.0% |
| Optum Insight · Operating Segments | 3,290 | 3,086 | +6.6% |
| Optum Insight · Operating Segments | 4,915 | 4,931 | -0.3% |
| Optum Rx · Operating Segments | 14,433 | 13,535 | +6.6% |
| Optum Rx · Operating Segments | 25,195 | 20,554 | +22.6% |
| Optum Rx · Operating Segments | 39,679 | 34,207 | +16.0% |
| Optum · Affiliated Customers | 43,086 | 37,958 | +13.5% |
| Optum · Unaffiliated Customers | 25,527 | 25,131 | +1.6% |
| UnitedHealthcare · Operating Segments | 86,502 | 74,046 | +16.8% |
| UnitedHealthcare · Operating Segments | 87,070 | 74,853 | +16.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -43,086 | -37,958 | -13.5% |
| Corporate Non Segment · Affiliated Customers | -43,086 | -37,958 | -13.5% |
| Intersegment Elimination | -1,317 | -1,130 | -16.5% |
| Intersegment Elimination · Affiliated Customers | -1,317 | -1,130 | -16.5% |
Show Major Customers breakouts |
|||
| Unaffiliated Customers | 112,029 | 99,177 | +13.0% |
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 13,296 | 12,631 | +5.3% |
| Product · Optum | 13,296 | 12,631 | +5.3% |
| Product · Optum Health | 61 | 84 | -27.4% |
| Product · Optum Insight | 45 | 41 | +9.8% |
| Product · Optum Rx | 13,190 | 12,506 | +5.5% |
| Product · Unaffiliated Customers | 13,296 | 12,631 | +5.3% |
| Service | 9,754 | 9,104 | +7.1% |
| Service · Optum | 7,176 | 6,682 | +7.4% |
| Service · Optum Health | 4,394 | 3,953 | +11.2% |
| Service · Optum Insight | 1,539 | 1,700 | -9.5% |
| Service · Optum Rx | 1,243 | 1,029 | +20.8% |
| Service · Unaffiliated Customers | 9,754 | 9,104 | +7.1% |
| Service · UnitedHealthcare | 2,578 | 2,422 | +6.4% |
| Policyholder Benefits And Claims Incurred Net | 79,958 | 65,957 | +21.2% |
| Selling, General & Administrative | 15,223 | 13,280 | +14.6% |
| Cost of Revenue | 12,566 | 11,834 | +6.2% |
| Depreciation And Amortization | 1,099 | 1,041 | +5.6% |
Show Business Segments breakouts |
|||
| Optum | 878 | 824 | +6.6% |
| Optum Health · Operating Segments | 309 | 283 | +9.2% |
| Optum Insight · Operating Segments | 359 | 332 | +8.1% |
| Optum Rx · Operating Segments | 210 | 209 | +0.5% |
| UnitedHealthcare · Operating Segments | 221 | 217 | +1.8% |
| Total Costs & Expenses | 108,846 | 92,112 | +18.2% |
Show Business Segments breakouts |
|||
| Optum | 66,667 | 59,429 | +12.2% |
| Optum Health · Operating Segments | 25,645 | 23,756 | +8.0% |
| Optum Insight · Operating Segments | 4,209 | 4,140 | +1.7% |
| Optum Rx · Operating Segments | 38,130 | 32,663 | +16.7% |
| UnitedHealthcare · Operating Segments | 85,265 | 70,641 | +20.7% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -43,086 | -37,958 | -13.5% |
| Intersegment Elimination | -1,317 | -1,130 | -16.5% |
| Operating Income | 4,315 | 8,708 | -50.4% |
Show Business Segments breakouts |
|||
| Optum | 2,510 | 4,496 | -44.2% |
| Optum Health · Operating Segments | 255 | 2,161 | -88.2% |
| Optum Insight · Operating Segments | 706 | 791 | -10.7% |
| Optum Rx · Operating Segments | 1,549 | 1,544 | +0.3% |
| UnitedHealthcare · Operating Segments | 1,805 | 4,212 | -57.1% |
| Interest Expense | -1,003 | -1,074 | +6.6% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -1,003 | -1,074 | +6.6% |
| Loss On Sale Of Subsidiary And Subsidiaries Held For Sale | -83 | -20 | -315.0% |
Show Business Segments breakouts |
|||
| UnitedHealthcare · Operating Segments | -83 | -20 | -315.0% |
| Income Before Taxes | 3,229 | 7,614 | -57.6% |
Show Business Segments breakouts |
|||
| Optum | 2,510 | 4,496 | -44.2% |
| Optum Health · Operating Segments | 255 | 2,161 | -88.2% |
| Optum Insight · Operating Segments | 706 | 791 | -10.7% |
| Optum Rx · Operating Segments | 1,549 | 1,544 | +0.3% |
| UnitedHealthcare · Operating Segments | 1,722 | 4,192 | -58.9% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -1,003 | -1,074 | +6.6% |
| Income Tax Expense (Benefit) | -686 | -1,356 | +49.4% |
| Net Income | 2,543 | 6,258 | -59.4% |
| Net Income Loss Attributable To Noncontrolling Interest | -195 | -203 | +3.9% |
| Net Income | 2,348 | 6,055 | -61.2% |
Show Equity Components breakouts |
|||
| Retained Earnings | 2,348 | 6,055 | -61.2% |
| EPS (Basic) | 2.59 | 6.56 | -60.5% |
| EPS (Diluted) | 2.59 | 6.51 | -60.2% |
| Wtd Avg Shares (Basic) | 906 | 923 | -1.8% |
| Weighted Average Number Diluted Shares Outstanding Adjustment | 2 | 7 | -71.4% |
| Wtd Avg Shares (Diluted) | 908 | 930 | -2.4% |
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount | 16 | 4 | +300.0% |
| Comprehensive Income | 2,672 | 7,025 | -62.0% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 27,210 | 32,400 | -16.0% |
| Short-Term Investments | 3,404 | 4,734 | -28.1% |
| Accounts Receivable | 22,672 | 20,024 | +13.2% |
Show Product Lines breakouts |
|||
| unh:ProductsandservicesMember | 10.1 | 9.2 | +9.8% |
| Other Receivables Net Current | 32,762 | 27,461 | +19.3% |
| Prepaid Expenses & Other Current Assets | 9,019 | 7,639 | +18.1% |
| Total Current Assets | 95,067 | 92,258 | +3.0% |
| Non-Current Assets | |||
| Long Term Investments | 52,996 | 48,689 | +8.8% |
| Property, Plant & Equipment | 11,104 | 10,139 | +9.5% |
| Goodwill | 110,340 | 105,978 | +4.1% |
| Other Non-Current Assets | 22,977 | 18,651 | +23.2% |
| Total Assets | 315,269 | 299,309 | +5.3% |
Show Business Segments breakouts |
|||
| Optum | 197,269 | 187,179 | +5.4% |
| Optum Health · Operating Segments | 100,895 | 95,482 | +5.7% |
| Optum Insight · Operating Segments | 33,846 | 34,666 | -2.4% |
| Optum Rx · Operating Segments | 62,528 | 57,031 | +9.6% |
| UnitedHealthcare · Operating Segments | 130,492 | 120,760 | +8.1% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -12,492 | -8,630 | -44.8% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 22,785 | 23,594 | -3.4% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense | 40,181 | 33,951 | +18.3% |
| Accounts Payable And Accrued Liabilities Current | 36,033 | 33,080 | +8.9% |
| Debt Current | 7,737 | 3,909 | +97.9% |
| Deferred Revenue | 3,366 | 3,320 | +1.4% |
| Other Liabilities Current | 28,209 | 27,305 | +3.3% |
| Total Current Liabilities | 115,526 | 101,565 | +13.7% |
| Commercial Paper (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Commercial Paper | 2.9 | 1.2 | +141.7% |
| Non-Current Liabilities | |||
| Long-Term Debt | 72,399 | 74,101 | -2.3% |
| Deferred Tax Liabilities | 3,162 | 4,014 | -21.2% |
| Other Non-Current Liabilities | 18,369 | 15,174 | +21.1% |
| Total Liabilities | 209,456 | 194,854 | +7.5% |
| Other Liabilities | |||
| Redeemable Noncontrolling Interest Equity Carrying Amount | 4,244 | 4,574 | -7.2% |
| Stockholders' Equity | |||
| Common Stock | 9 | 9 | 0.0% |
| Additional Paid-In Capital | 394 | 461 | -14.5% |
| Retained Earnings | 97,595 | 96,518 | +1.1% |
| Accumulated Other Comprehensive Income | -2,211 | -2,453 | +9.9% |
| Minority Interest | 5,782 | 5,346 | +8.2% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 101,569 | 99,881 | +1.7% |
Show Equity Components breakouts |
|||
| Accumulated Net Unrealized Investment Gain Loss | -1,198 | -1,414 | +15.3% |
| Accumulated Translation Adjustment | -1,013 | -1,039 | +2.5% |
| Additional Paid In Capital | 394 | 461 | -14.5% |
| Common Stock | 9 | 9 | 0.0% |
| Noncontrolling Interest | 5,782 | 5,346 | +8.2% |
| Retained Earnings | 97,595 | 96,518 | +1.1% |
| Total Liabilities & Equity | 315,269 | 299,309 | +5.3% |
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.0% |
| Common Stock Shares Authorized | 3,000 | 3,000 | 0.0% |
| Common Stock Shares Issued | 906 | 923 | -1.8% |
| Common Stock Shares Outstanding | 906 | 923 | -1.8% |
Show Equity Components breakouts |
|||
| Common Stock | 906 | 923 | -1.8% |
| Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0.0% |
| Preferred Stock Shares Authorized | 10 | 10 | 0.0% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Deferred Income Taxes | -1,019 | -234 | -335.5% |
| Stock-Based Compensation | 795 | 831 | -4.3% |
| Other Non-Cash Items | 64 | -610 | +110.5% |
| Change in Accounts Receivable | 65 | 685 | -90.5% |
| Increase Decrease In Other Operating Assets | -3,105 | -2,988 | -3.9% |
| Increase Decrease In Health Care Insurance Liabilities | 6,178 | 2,235 | +176.4% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -417 | 1,250 | -133.4% |
| Increase Decrease In Deferred Revenue | 56 | -181 | +130.9% |
| Net Cash from Operations | 18,589 | 21,835 | -14.9% |
| Investing Activities | |||
| Payments To Acquire Investments | -12,805 | -19,951 | +35.8% |
| Proceeds From Sale Of Available For Sale Securities Debt | 7,945 | 15,065 | -47.3% |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 6,517 | 6,738 | -3.3% |
| Payments To Acquire Businesses Net Of Cash Acquired | -4,436 | -11,674 | +62.0% |
| Capital Expenditures | -2,674 | -2,587 | -3.4% |
| Repayments Of Care Provider Loans Cyberattack | 1,543 | 3,189 | -51.6% |
| Other Investing Activities | -2,164 | -1,284 | -68.5% |
| Net Cash from Investing | -6,074 | -19,408 | +68.7% |
| Financing Activities | |||
| Share Repurchases | -5,545 | -4,028 | -37.7% |
| Payments Of Dividends Common Stock | -5,914 | -5,601 | -5.6% |
| Proceeds From Issuance Of Common Stock | 803 | 1,611 | -50.2% |
| Repayments Of Long Term Debt | -2,000 | -2,500 | +20.0% |
| Proceeds From Repayments Of Commercial Paper | 1,469 | -191 | +869.1% |
| Proceeds From Issuance Of Long Term Debt | 2,969 | 17,811 | -83.3% |
| Increase Decrease In Deposits | -1,792 | -1,059 | -69.2% |
| Proceeds From Payments For Other Financing Activities | -603 | -1,213 | +50.3% |
| Net Cash from Financing | -10,613 | 4,830 | -319.7% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 25 | -30 | +183.3% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations | 1,927 | 7,227 | -73.3% |
| Increase In Cash Within Businesses Held For Sale | -29 | -254 | +88.6% |
| Net Change in Cash | 1,898 | 6,973 | -72.8% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 27,210 | 32,400 | -16.0% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.